Cargando…

Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma

INTRODUCTION: Histiocytic Sarcoma (HS) is a rare and aggressive malignancy, and patients can present with rapid tumor growth and invasion. The optimal diagnostic and therapeutic management is unknown since only a few cases have been published. Here we report a patient with histiocytic sarcoma of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehrmann, Stefan, Rudolph, Hagen, Ernst, Dominikus, Siepmann, Timo, Kaltofen, Dorothea, Hänel, Mathias, Mirow, Lutz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215356/
https://www.ncbi.nlm.nih.gov/pubmed/34164336
http://dx.doi.org/10.3389/fonc.2021.633215
_version_ 1783710235107524608
author Wehrmann, Stefan
Rudolph, Hagen
Ernst, Dominikus
Siepmann, Timo
Kaltofen, Dorothea
Hänel, Mathias
Mirow, Lutz
author_facet Wehrmann, Stefan
Rudolph, Hagen
Ernst, Dominikus
Siepmann, Timo
Kaltofen, Dorothea
Hänel, Mathias
Mirow, Lutz
author_sort Wehrmann, Stefan
collection PubMed
description INTRODUCTION: Histiocytic Sarcoma (HS) is a rare and aggressive malignancy, and patients can present with rapid tumor growth and invasion. The optimal diagnostic and therapeutic management is unknown since only a few cases have been published. Here we report a patient with histiocytic sarcoma of the right groin. CASE: A 68 year-old male patient presented to our hospital with suspicion of a superinfected atheroma of the right groin. Computed tomography showed an abdominal tumor of unknown entity. Detailed assessment including immunohistochemically evaluation of biopsy material confirmed HS. The patient underwent radical tumor resection including compartment-resection of the right thigh. During five additional cycles of chemotherapy over a period of 1.5 years he remained relapse-free. SUMMARY: Diagnostic work up and treatment of HS is challenging, as there is a paucity of clinical reports and lack of standard guidelines for care. In the present case report, aggressive multidisciplinary treatment resulted in good clinical outcome, however, further studies evaluating this approach in similar patients are needed.
format Online
Article
Text
id pubmed-8215356
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82153562021-06-22 Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma Wehrmann, Stefan Rudolph, Hagen Ernst, Dominikus Siepmann, Timo Kaltofen, Dorothea Hänel, Mathias Mirow, Lutz Front Oncol Oncology INTRODUCTION: Histiocytic Sarcoma (HS) is a rare and aggressive malignancy, and patients can present with rapid tumor growth and invasion. The optimal diagnostic and therapeutic management is unknown since only a few cases have been published. Here we report a patient with histiocytic sarcoma of the right groin. CASE: A 68 year-old male patient presented to our hospital with suspicion of a superinfected atheroma of the right groin. Computed tomography showed an abdominal tumor of unknown entity. Detailed assessment including immunohistochemically evaluation of biopsy material confirmed HS. The patient underwent radical tumor resection including compartment-resection of the right thigh. During five additional cycles of chemotherapy over a period of 1.5 years he remained relapse-free. SUMMARY: Diagnostic work up and treatment of HS is challenging, as there is a paucity of clinical reports and lack of standard guidelines for care. In the present case report, aggressive multidisciplinary treatment resulted in good clinical outcome, however, further studies evaluating this approach in similar patients are needed. Frontiers Media S.A. 2021-06-07 /pmc/articles/PMC8215356/ /pubmed/34164336 http://dx.doi.org/10.3389/fonc.2021.633215 Text en Copyright © 2021 Wehrmann, Rudolph, Ernst, Siepmann, Kaltofen, Hänel and Mirow https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Wehrmann, Stefan
Rudolph, Hagen
Ernst, Dominikus
Siepmann, Timo
Kaltofen, Dorothea
Hänel, Mathias
Mirow, Lutz
Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma
title Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma
title_full Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma
title_fullStr Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma
title_full_unstemmed Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma
title_short Case Report: Eighteen Month Relapse- Free Survival Following Radical Multidisciplinary Oncological Treatment in a 68-Year-Old Male Patient With Histiocytic Sarcoma
title_sort case report: eighteen month relapse- free survival following radical multidisciplinary oncological treatment in a 68-year-old male patient with histiocytic sarcoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215356/
https://www.ncbi.nlm.nih.gov/pubmed/34164336
http://dx.doi.org/10.3389/fonc.2021.633215
work_keys_str_mv AT wehrmannstefan casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma
AT rudolphhagen casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma
AT ernstdominikus casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma
AT siepmanntimo casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma
AT kaltofendorothea casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma
AT hanelmathias casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma
AT mirowlutz casereporteighteenmonthrelapsefreesurvivalfollowingradicalmultidisciplinaryoncologicaltreatmentina68yearoldmalepatientwithhistiocyticsarcoma